May 11, 2012

Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.

March 15, 2012

A drug under investigation by Teva Pharmaceutical Industries and Active Biotech reduced symptoms and progression of disease in patients with multiple sclerosis, according to results of a late-stage clinical trial.

October 5, 2011

Schiff Nutrition International on Wednesday named Shane Durkee SVP research and development.

November 1, 2010

Amgen's SVP research and development, Joe Miletich, urged members of a Food and Drug Administration...